Home › Neuroblastoma › Hawaii
Neuroblastoma clinical trials in Hawaii
6 studies for Neuroblastoma are looking for participants at sites in Hawaii.
Cities in Hawaii
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 3
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 2
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 2
Ages 1 to 21 · All sexes · Updated Sep 3, 2026 · NCT06540963Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 2
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.